NCT01074450View on ClinicalTrials.gov

Pramipexole Dihydrochloride 0.25 mg Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

March 31, 2005

Study Completion Date

March 31, 2005

Conditions
Healthy
Interventions
DRUG

Pramipexole Dihydrochloride

0.25 mg Tablet

DRUG

Pramipexole Dihydrochloride

0.25 mg Tablet

Trial Locations (1)

58104

PRACS Institute, Ltd., Fargo

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT01074450 - Pramipexole Dihydrochloride 0.25 mg Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter